Matches in SemOpenAlex for { <https://semopenalex.org/work/W2279777300> ?p ?o ?g. }
- W2279777300 endingPage "16324" @default.
- W2279777300 startingPage "16311" @default.
- W2279777300 abstract "As a natural health supplement, 3,3'-diindolylmethane (DIM) is proposed as a preventive and chemotherapeutic agent for cancer by inhibiting cell proliferation and inducing cell apoptosis. However, we found that in contrary to high level of DIM (30 μM), low level of DIM (1 μM and 10 μM) obviously promoted gastric cancer cell growth and migration. In addition, we found that low level of DIM increased the expression of stemness factors and enhanced the pluripotency of gastric cancer cells. Low level of DIM promoted gastric cancer progression by inducing the PORCN-dependent secretion of Wnt4 and the activation of β-catenin signaling. Wnt4 knockdown reversed the effects of low level of DIM on gastric cancer cells. The results of in vivo studies showed that gastric cancer cells treated with low level of DIM (1 μM) grew faster and expressed higher level of Wnt4 than control cells. Taken together, our findings indicate that low level of DIM activates autocrine Wnt4 signaling to enhance the progression of gastric cancer, which may suggest an adverse aspect of DIM in cancer therapy. Our findings will provide a new aspect for the safety of DIM in its clinical application." @default.
- W2279777300 created "2016-06-24" @default.
- W2279777300 creator A5004643008 @default.
- W2279777300 creator A5017057369 @default.
- W2279777300 creator A5026641220 @default.
- W2279777300 creator A5027924175 @default.
- W2279777300 creator A5046881277 @default.
- W2279777300 creator A5049154513 @default.
- W2279777300 creator A5051242165 @default.
- W2279777300 creator A5060916748 @default.
- W2279777300 creator A5067238930 @default.
- W2279777300 creator A5072730511 @default.
- W2279777300 creator A5075219319 @default.
- W2279777300 creator A5081351303 @default.
- W2279777300 creator A5086560872 @default.
- W2279777300 date "2016-02-24" @default.
- W2279777300 modified "2023-10-17" @default.
- W2279777300 title "Anti-cancer drug 3,3′-diindolylmethane activates Wnt4 signaling to enhance gastric cancer cell stemness and tumorigenesis" @default.
- W2279777300 cites W1874168860 @default.
- W2279777300 cites W1923089477 @default.
- W2279777300 cites W1961471672 @default.
- W2279777300 cites W1964224339 @default.
- W2279777300 cites W1972256954 @default.
- W2279777300 cites W1977162998 @default.
- W2279777300 cites W1980722224 @default.
- W2279777300 cites W1994029539 @default.
- W2279777300 cites W2006419043 @default.
- W2279777300 cites W2008585474 @default.
- W2279777300 cites W2009113565 @default.
- W2279777300 cites W2015846126 @default.
- W2279777300 cites W2040498499 @default.
- W2279777300 cites W2044249881 @default.
- W2279777300 cites W2049717090 @default.
- W2279777300 cites W2051055358 @default.
- W2279777300 cites W2053363358 @default.
- W2279777300 cites W2056694303 @default.
- W2279777300 cites W2069110658 @default.
- W2279777300 cites W2069322567 @default.
- W2279777300 cites W2076007300 @default.
- W2279777300 cites W2077033018 @default.
- W2279777300 cites W2083798214 @default.
- W2279777300 cites W2086738288 @default.
- W2279777300 cites W2090001690 @default.
- W2279777300 cites W2090982381 @default.
- W2279777300 cites W2101569447 @default.
- W2279777300 cites W2102085111 @default.
- W2279777300 cites W2107476734 @default.
- W2279777300 cites W2107587741 @default.
- W2279777300 cites W2107873095 @default.
- W2279777300 cites W2110838173 @default.
- W2279777300 cites W2122212876 @default.
- W2279777300 cites W2124356784 @default.
- W2279777300 cites W2126842347 @default.
- W2279777300 cites W2131069942 @default.
- W2279777300 cites W2133252611 @default.
- W2279777300 cites W2136601392 @default.
- W2279777300 cites W2136798908 @default.
- W2279777300 cites W2142755954 @default.
- W2279777300 cites W2145028201 @default.
- W2279777300 cites W2145142940 @default.
- W2279777300 cites W2149598894 @default.
- W2279777300 cites W2155009953 @default.
- W2279777300 cites W2155649041 @default.
- W2279777300 cites W2156632738 @default.
- W2279777300 cites W2157501227 @default.
- W2279777300 cites W2159298094 @default.
- W2279777300 cites W2164698132 @default.
- W2279777300 cites W2301361857 @default.
- W2279777300 cites W2442128930 @default.
- W2279777300 cites W273038247 @default.
- W2279777300 doi "https://doi.org/10.18632/oncotarget.7684" @default.
- W2279777300 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4941316" @default.
- W2279777300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26918831" @default.
- W2279777300 hasPublicationYear "2016" @default.
- W2279777300 type Work @default.
- W2279777300 sameAs 2279777300 @default.
- W2279777300 citedByCount "20" @default.
- W2279777300 countsByYear W22797773002016 @default.
- W2279777300 countsByYear W22797773002017 @default.
- W2279777300 countsByYear W22797773002018 @default.
- W2279777300 countsByYear W22797773002019 @default.
- W2279777300 countsByYear W22797773002020 @default.
- W2279777300 countsByYear W22797773002021 @default.
- W2279777300 countsByYear W22797773002023 @default.
- W2279777300 crossrefType "journal-article" @default.
- W2279777300 hasAuthorship W2279777300A5004643008 @default.
- W2279777300 hasAuthorship W2279777300A5017057369 @default.
- W2279777300 hasAuthorship W2279777300A5026641220 @default.
- W2279777300 hasAuthorship W2279777300A5027924175 @default.
- W2279777300 hasAuthorship W2279777300A5046881277 @default.
- W2279777300 hasAuthorship W2279777300A5049154513 @default.
- W2279777300 hasAuthorship W2279777300A5051242165 @default.
- W2279777300 hasAuthorship W2279777300A5060916748 @default.
- W2279777300 hasAuthorship W2279777300A5067238930 @default.
- W2279777300 hasAuthorship W2279777300A5072730511 @default.
- W2279777300 hasAuthorship W2279777300A5075219319 @default.
- W2279777300 hasAuthorship W2279777300A5081351303 @default.
- W2279777300 hasAuthorship W2279777300A5086560872 @default.